Literature DB >> 32581077

COVID-19 Hyperinflammation: What about Neutrophils?

Athanasios Didangelos1.   

Abstract

COVID-19 is often related to hyperinflammation that drives lung or multiorgan injury. The immunopathological mechanisms that cause excessive inflammation are under investigation and constantly updated. Here, a gene network approach was used on recently published data sets to identify possible COVID-19 inflammatory mechanisms and bioactive genes. First, network analysis of putative SARS-CoV-2 cellular receptors led to the mining of a neutrophil-response signature and relevant inflammatory genes. Second, analysis of RNA-seq data sets of lung cells infected with SARS-CoV-2 revealed that infected cells expressed neutrophil-attracting chemokines. Third, analysis of RNA-seq data sets of bronchoalveolar lavage fluid cells from COVID-19 patients identified upregulation of neutrophil genes and chemokines. Different inflammatory genes mined here, including TNFR, IL-8, CXCR1, CXCR2, ADAM10, GPR84, MME, ANPEP, and LAP3, might be druggable targets in efforts to limit SARS-CoV-2 inflammation in severe clinical cases. The possible role of neutrophils in COVID-19 inflammation needs to be studied further.
Copyright © 2020 Didangelos.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; inflammation; neutrophil

Mesh:

Substances:

Year:  2020        PMID: 32581077      PMCID: PMC7316488          DOI: 10.1128/mSphere.00367-20

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  19 in total

1.  A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection.

Authors:  Marlène Brandes; Frederick Klauschen; Stefan Kuchen; Ronald N Germain
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

2.  Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology.

Authors:  Anoria K Haick; Joanna P Rzepka; Elizabeth Brandon; Onesmo B Balemba; Tanya A Miura
Journal:  J Gen Virol       Date:  2013-12-09       Impact factor: 3.891

3.  Dysregulation of lung myeloid cells in COVID-19.

Authors:  Bérengère Salomé; Assaf Magen
Journal:  Nat Rev Immunol       Date:  2020-05       Impact factor: 53.106

4.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

Review 5.  Neutrophil in viral infections, friend or foe?

Authors:  Brandon Drescher; Fengwei Bai
Journal:  Virus Res       Date:  2012-11-21       Impact factor: 3.303

6.  Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells.

Authors:  Matthew M Hufford; Graham Richardson; Haixia Zhou; Balaji Manicassamy; Adolfo García-Sastre; Richard I Enelow; Thomas J Braciale
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 7.  The trinity of COVID-19: immunity, inflammation and intervention.

Authors:  Matthew Zirui Tay; Chek Meng Poh; Laurent Rénia; Paul A MacAry; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 108.555

8.  Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.

Authors:  Furong Qi; Shen Qian; Shuye Zhang; Zheng Zhang
Journal:  Biochem Biophys Res Commun       Date:  2020-03-19       Impact factor: 3.575

9.  Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Authors:  Andrew I Ritchie; Aran Singanayagam
Journal:  Lancet       Date:  2020-03-24       Impact factor: 79.321

10.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients.

Authors:  Meijuan Zheng; Yong Gao; Gang Wang; Guobin Song; Siyu Liu; Dandan Sun; Yuanhong Xu; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-03-19       Impact factor: 11.530

View more
  47 in total

Review 1.  Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.

Authors:  Ashley A Stegelmeier; Maedeh Darzianiazizi; Kiersten Hanada; Shayan Sharif; Sarah K Wootton; Byram W Bridle; Khalil Karimi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

2.  African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures.

Authors:  Urminder Singh; Kyle M Hernandez; Bruce J Aronow; Eve Syrkin Wurtele
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

3.  Role of the Immune Microenvironment in SARS-CoV-2 Infection.

Authors:  Chih-Hung Ye; Wen-Lin Hsu; Guan-Ru Peng; Wei-Chieh Yu; Wei-Chen Lin; SuiYun Hu; Shu-Han Yu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

4.  Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives.

Authors:  Saber Marzouk; Noha Attia; Mohamed Mashal
Journal:  Clin Respir J       Date:  2021-07-12       Impact factor: 1.761

5.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

6.  [Role of the immune system in SARS-CoV-2 infection: immunopathology of COVID-19].

Authors:  J Monserrat Sanz; A M Gómez Lahoz; R Oliva Martín
Journal:  Medicine (Madr)       Date:  2021-05-27

Review 7.  Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.

Authors:  Pankaj Ahluwalia; Kumar Vaibhav; Meenakshi Ahluwalia; Ashis K Mondal; Nikhil Sahajpal; Amyn M Rojiani; Ravindra Kolhe
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

8.  Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.

Authors:  M Babul Islam; Utpala Nanda Chowdhury; Zulkar Nain; Shahadat Uddin; Mohammad Boshir Ahmed; Mohammad Ali Moni
Journal:  Comput Biol Med       Date:  2021-07-23       Impact factor: 4.589

Review 9.  Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Authors:  Danielle Brain; Alex Plant-Hately; Bethany Heaton; Usman Arshad; Christopher David; Christian Hedrich; Andrew Owen; Neill J Liptrott
Journal:  Adv Drug Deliv Rev       Date:  2021-06-25       Impact factor: 17.873

10.  Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI.

Authors:  Fabian Bohländer; Dennis Riehl; Sabrina Weißmüller; Marcus Gutscher; Jörg Schüttrumpf; Stefanie Faust
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.